Cargando…
Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma
Sorafenib, a multikinase inhibitor, is approved for treatment of renal cell cancer and hepatocellular cancer. Hand-foot syndrome (HFD) is a condition where erythema, scaling, and bullous lesion affect the hand and feet. In this case, a post-nephrectomy renal carcinoma patient prescribed sorafenib de...
Autores principales: | Sil, Amrita, Das, Nilay Kanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071713/ https://www.ncbi.nlm.nih.gov/pubmed/24987183 http://dx.doi.org/10.4103/0253-7613.132189 |
Ejemplares similares
-
Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myeloma
por: Das, Anupam, et al.
Publicado: (2014) -
Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge
por: Badarkhe, Girish V., et al.
Publicado: (2016) -
Azithromycin induced bullous fixed drug eruption
por: Das, Anupam, et al.
Publicado: (2016) -
Rare occurrence of hand-foot syndrome due to paclitaxel: A rare case report
por: Kataria, Pritam S., et al.
Publicado: (2018) -
An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
por: Vasudevan, Biju
Publicado: (2010)